Immuneering Corporation

Immuneering Corporation - PE Ratioverified

IMRX

Price:

$4.41

Market Cap:

$160.09M

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS and/or RAF gene mutations. The second is IMM-6-415, which is being developed to treat solid tumors. Beyond these advanced-stage programs, Immuneering's early-stage pipeline includes five oncology initiatives aimed at components of the MAPK or mTOR signaling pathways, along with tw...[Read more]

Industry

Biotechnology

IPO Date

2021-07-30

Stock Exchange

NASDAQ

Ticker

IMRX

The PE Ratio as of June 2026 (TTM) for Immuneering Corporation (IMRX) is -4.16

According to Immuneering Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -4.16. This represents a change of -24.79% compared to the average of -5.53 of the last 4 quarters.

Immuneering Corporation (IMRX) Historical PE Ratio (quarterly & annually)

How has IMRX PE Ratio performed in the past?

The mean historical PE Ratio of Immuneering Corporation over the last ten years is -9.82. The current -4.16 PE Ratio has changed 4.13% with respect to the historical average. Over the past ten years (40 quarters), IMRX's PE Ratio was at its highest in in the March 2023 quarter at 0.06. The PE Ratio was at its lowest in in the March 2020 quarter at -18.32.

Quarterly (TTM)
Annual

Average

-9.82

Median

-5.18

Minimum

-29.32

Maximum

-1.08

Immuneering Corporation (IMRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immuneering Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 380.43%

Maximum Annual PE Ratio = -1.08

Minimum Annual Increase = -79.63%

Minimum Annual PE Ratio = -29.32

Quarterly (TTM)
Annual
YearPE RatioChange
2025-5.18380.43%
2024-1.08-72.42%
2023-3.9150.74%
2022-2.59-79.63%
2021-12.73-8.80%
2020-13.96-52.38%

Immuneering Corporation (IMRX) Average PE Ratio

How has IMRX PE Ratio performed in the past?

The current PE Ratio of Immuneering Corporation (IMRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.39

5-year avg

-5.10

10-year avg

-9.82

Immuneering Corporation (IMRX) PE Ratio vs. Peers

How is IMRX’s PE Ratio compared to its peers?

Immuneering Corporation’s PE Ratio is less than Foghorn Therapeutics Inc. (-3.55), less than Pyxis Oncology, Inc. (-1.55), greater than Nautilus Biotechnology, Inc. (-4.96), less than Zura Bio Limited (-3.44), less than Humacyte, Inc. (-1.57), greater than Assembly Biosciences, Inc. (-42.14), greater than Enanta Pharmaceuticals, Inc. (-4.62), less than Arcturus Therapeutics Holdings Inc. (-2.66), less than Tenaya Therapeutics, Inc. (-1.55), less than Entrada Therapeutics, Inc. (-1.77),

Build a custom stock screener for Immuneering Corporation (IMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immuneering Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immuneering Corporation (IMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immuneering Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Immuneering Corporation's PE Ratio?

How is the PE Ratio calculated for Immuneering Corporation (IMRX)?

What is the highest PE Ratio for Immuneering Corporation (IMRX)?

What is the 3-year average PE Ratio for Immuneering Corporation (IMRX)?

What is the 5-year average PE Ratio for Immuneering Corporation (IMRX)?

How does the current PE Ratio for Immuneering Corporation (IMRX) compare to its historical average?